News

The UK government has created two new Enterprise Capital Funds (ECF) under its £40 million scheme to aid high tech businesses caught in the equity gap.

With global revenues of $110 billion last year, and an aging population, the nascent "neurotechnology" market appears poised for huge growth.

Frost & Sullivan puts some flesh on the bones of the idea that nanotechnology can be a profitable tool in drug development.

Nanomedicine can be more than a case of adding a trendy label to traditional approaches to pharmaceuticals.

Last week's Innovate2006 conference in Zaragoza included a pre-conference tour of the region with an interesting visit of Endesa and one of the largest Spanish windmill farms, located just a few miles north off Zaragoza.

Yet another consultation is under way into the safety of nanotechnology. This time you have an opportunity to give your views on "the use of nanotechnologies in relation to food".

Intellectual property battles are not always settled in the marketplace. Epic, life-and-death struggles often take place in the judicial arena.

OncoMethylome Sciences is planning to raise funds via an IPO. Its diagnostics can detect early-stage cancer and predict the response to particular cancer drugs.

Manchester Metropolitan University has recruited academic and industrial partners to a £5 million programme that will assess the problems confronting the global airline industry and help to develop solutions.

A cross-continent project to develop fusion as an energy source has moved once step closer to reality with the signing of a formal agreement.